244 related articles for article (PubMed ID: 36891053)
1. To block or not to block-hormonal signaling in the treatment of cancers.
Abikar A; Saimon C; Ranganathan P
Front Endocrinol (Lausanne); 2023; 14():1129332. PubMed ID: 36891053
[TBL] [Abstract][Full Text] [Related]
2. Sex steroid hormone metabolism and prostate cancer.
Soronen P; Laiti M; Törn S; Härkönen P; Patrikainen L; Li Y; Pulkka A; Kurkela R; Herrala A; Kaija H; Isomaa V; Vihko P
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):281-6. PubMed ID: 15663991
[TBL] [Abstract][Full Text] [Related]
3. Endocrine therapy: where do we stand and where are we going?
Schröder FH
Cancer Surv; 1991; 11():177-94. PubMed ID: 1841751
[TBL] [Abstract][Full Text] [Related]
4. Is dehydroepiandrosterone a hormone?
Labrie F; Luu-The V; Bélanger A; Lin SX; Simard J; Pelletier G; Labrie C
J Endocrinol; 2005 Nov; 187(2):169-96. PubMed ID: 16293766
[TBL] [Abstract][Full Text] [Related]
5. Basis for hormonal management of advanced prostate cancer.
Geller J
Cancer; 1993 Feb; 71(3 Suppl):1039-45. PubMed ID: 7679038
[TBL] [Abstract][Full Text] [Related]
6. Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review.
Anbarasu S; Anbarasu A
Med Oncol; 2023 May; 40(6):171. PubMed ID: 37162589
[TBL] [Abstract][Full Text] [Related]
7. Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.
Jordan VC; Fan P; Abderrahman B; Maximov PY; Hawsawi YM; Bhattacharya P; Pokharel N
Discov Med; 2016 May; 21(117):411-27. PubMed ID: 27355337
[TBL] [Abstract][Full Text] [Related]
8. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
Platz EA; Giovannucci E
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
[TBL] [Abstract][Full Text] [Related]
10. Androgens and prostate cancer: biology, pathology and hormonal therapy.
Galbraith SM; Duchesne GM
Eur J Cancer; 1997 Apr; 33(4):545-54. PubMed ID: 9274433
[No Abstract] [Full Text] [Related]
11. Advantages of total androgen blockade in the treatment of advanced prostate cancer.
Geller J; Albert J; Vik A
Semin Oncol; 1988 Apr; 15(2 Suppl 1):53-61. PubMed ID: 3285484
[TBL] [Abstract][Full Text] [Related]
12. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Modulation of Steroid Activity in Hormone-Dependent Breast and Prostate Cancers: Effect of Some Plant Extract Derivatives.
Bayala B; Zoure AA; Baron S; de Joussineau C; Simpore J; Lobaccaro JA
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456259
[No Abstract] [Full Text] [Related]
14. Intra-prostatic androgen levels during various androgen-blockade regimens.
Nishiyama T
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):229-41. PubMed ID: 18471782
[TBL] [Abstract][Full Text] [Related]
15. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
16. Hormonal therapy of prostate cancer.
Labrie F
Prog Brain Res; 2010; 182():321-41. PubMed ID: 20541672
[TBL] [Abstract][Full Text] [Related]
17. Endocrine treatment in prostate cancer.
Denis LJ; Griffiths K
Semin Surg Oncol; 2000; 18(1):52-74. PubMed ID: 10617897
[TBL] [Abstract][Full Text] [Related]
18. Novel hormonal approaches in prostate cancer.
Friedlander TW; Ryan CJ
Curr Oncol Rep; 2009 May; 11(3):227-34. PubMed ID: 19336015
[TBL] [Abstract][Full Text] [Related]
19. Hormonal management of prostate cancer.
Wasan HS; Waxman J
Clin Endocrinol (Oxf); 1992 Dec; 37(6):477-80. PubMed ID: 1286518
[TBL] [Abstract][Full Text] [Related]
20. Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer.
Montgomery B; Nelson PS; Vessella R; Kalhorn T; Hess D; Corey E
BMC Cancer; 2010 May; 10():244. PubMed ID: 20509933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
